Evidence map›Paper›PMID 31807099›Full record

ArticleRisk management and healthcare policy2019

Machine Learning For Tuning, Selection, And Ensemble Of Multiple Risk Scores For Predicting Type 2 Diabetes.

Yujia Liu, Shangyuan Ye, Xianchao Xiao, Chenglin Sun, Gang Wang, Guixia Wang, Bo Zhang

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Machine learning for diabetes clinical decision support: a review.Advances in computational intelligence · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yujia LiuDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, People's Republic of China.
Shangyuan YeDepartment of Population Medicine, Harvard Pilgrim Health Care and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7504-8215
Xianchao XiaoDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, People's Republic of China.
Chenglin SunDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, People's Republic of China.ORCID 0000-0003-3570-1918
Gang WangDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, People's Republic of China.
Guixia WangDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, People's Republic of China.
Bo ZhangDepartment of Neurology and ICCTR Biostatistics and Research Design Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1574-198X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study proposes the use of machine learning algorithms to improve the accuracy of type 2 diabetes predictions using non-invasive risk score systems.

methodsWe evaluated and compared the prediction accuracies of existing non-invasive risk score systems using the data from the REACTION study (Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal Study). Two simple risk scores were established on the bases of logistic regression. Machine learning techniques (ensemble methods) were used to improve prediction accuracies by combining the individual score systems.

resultsExisting score systems from Western populations performed worse than the scores from Eastern populations in general. The two newly established score systems performed better than most existing scores systems but a little worse than the Chinese score system. Using ensemble methods with model selection algorithms yielded better prediction accuracy than all the simple score systems.

conclusionOur proposed machine learning methods can be used to improve the accuracy of screening the undiagnosed type 2 diabetes and identifying the high-risk patients.

Indexed as

machine learningpredictionrisk scorestackingtype 2 diabetesvoting

Identifiers

PMID31807099
PMCPMC6842709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.